depression glp 1 GLP-1 Drug Improved Motivation in Major Depressive Disorder Targeting the GLP-1 receptor pathways

Pan H-C, Chen J-Y, Chen H-Y, Yeh F-Y, Sun C-Y, Huang TT-M, et al

While Medicare currently is prohibited by statute from covering weight-loss-only medications, the Center for Medicare and Medicaid Innovation has the authority to design and test new payment models that lower program spending while maintaining or improving the quality of care

To better understand those early experiences, we asked 250 GLP-1 users what they wish they'd known before getting started

But the researchers point out that the clinical trials for GLP-1 drugs excluded people with mood disorders and a history of suicide attempts leaving out those with bipolar disorder

J Clin Endo & Metab

Should we expect those insurance premiums to keep going up or has the impact of GLP-1s mostly been factored in at this point